GlaxoSmithKline plc http://www.alacrastore.com/company-snapshot/GlaxoSmithKline_plc-1007127 08 Nov 2009 06:12:22 EST 1007127 GlaxoSmithKline plc en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/newstex/MCOM-0004-39460563MCOM-0004-39460563newstex/MCOM-0004-39460563xmlNewstex Inc.2005Copyright (c) M2 Communications Ltd.Newstex Inc.newstex.comnewstexMCOM-0004-39460563M2 EquityBites0004M2 Communications Ltd.MCOM1Newstex Inc.M207000000070140000701401207003000070030010400000004016000040160130400200004002006040060000400600505 Nov 2009 11:18:11 EST18000000180150001802200011/5/2009 Nov. #, #### (M# Communications Ltd. delivered by Newstex) -- Healthcare company GlaxoSmithKline plc (GSK) (LSE:GSK) confirmed on Tuesday the launch of a new specialist HIV company in partnership with pharmaceutical group Pfizer Inc...GLAXOSMITHKLINE PLCPFIZER INCGSKPFENewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-39422386BW-0001-39422386newstex/BW-0001-39422386xmlNewstex Inc.2005Synta Pharmaceuticals Corp.Newstex Inc.newstex.comnewstexBW-0001-39422386Business Wire0001Business WireBW1Newstex Inc.Business Wire070000000700500004000000040020000400200604016000040160180401600104016003040160130701400007014012070030000700300113000000130100001301000504 Nov 2009 08:26:54 EST1800000018004000180220001801500011/4/2009 Nov. #, #### (Business Wire) -- Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported...GLAXOSMITHKLINE PLCSYNTA PHARMACEUTICALS CORP.GSKSNTANewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-39370312BW-0001-39370312newstex/BW-0001-39370312xmlNewstex Inc.2005Parker Waichman Alonso LLPNewstex Inc.newstex.comnewstexBW-0001-39370312Business Wire0001Business WireBW1Newstex Inc.Business Wire0400000004012000040120040200000002002000020020040200200607000000070140000701401902 Nov 2009 04:27:45 EST180000001801400011/2/2009 Nov. #, #### (Business Wire) -- Parker Waichman Alonso LLP announces that they have filed a lawsuit against GlaxoSmithKline and Proctor & Gamble on behalf of an Iowa woman who was diagnosed with neuropathy attributed to the use of...GLAXOSMITHKLINE PLCGSKNewsNewstexhttp://www.alacrastore.com/research/fitch-ratings-GlaxoSmithKline_PLC-478646_report_frame478646_report_framefitch/478646_report_framepdfGlaxoSmithKline plc8045797231 Oct 2009 10:21:00 EST01031700165Credit UpdateGSKFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.Credit & Investment ResearchFitch Researchhttp://www.alacrastore.com/research/fitch-ratings-Fitch_European_Pharma_Faces_Declining_Profitability_on_Diversification_Pressures-524736_pr_frame524736_pr_framefitch/524736_pr_framehtmlGlaxoSmithKline plcBayer AGSanofi-Aventis S.A.Smithkline Beecham CorporationRoche Holding Ltd.Novartis AGAstraZeneca plcGlaxosmithkline Finance Plc811087178045797681108707803624348258868380457972804579798588407329 Oct 2009 10:17:00 EST0103170085Press ReleaseGSKBAYNRONOVNSANAZNFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.Credit & Investment ResearchFitch Researchhttp://www.alacrastore.com/storecontent/ccbn/T2039548T2039548ccbn/T2039548norm28 Oct 2009 02:08:13 EST2039548Final Transcript of GSK earnings conference call or presentation, 28-Oct-09 1:30pm UKTGlaxoSmithKline106.0000FinalGlaxoSmithKline Q3 2009 Earnings Conference Call TranscriptGSK1:30pm UKTTranscript...Andrew Baum Morgan Stanley - Analyst Gbola Amusa UBS - Analyst Tim Anderson Sanford C. Bernstein & Company, Inc. - Analyst Alexandra Hauber JPMorgan - Analyst Graham Parry BAS-ML - Analyst Kevin Wilson Citigroup - Analyst... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/B2039548B2039548ccbn/B2039548norm28 Oct 2009 02:08:00 EST2039548Edited Brief of GSK earnings conference call or presentation, 28-Oct-09 1:30pm UKTGlaxoSmithKline106.0000EditedGlaxoSmithKline Q3 2009 Earnings Conference Call SummaryGSK1:30pm UKT...Andrew Baum Morgan Stanley - Analyst Gbola Amusa UBS - Analyst Tim Anderson Sanford C. Bernstein & Company, Inc. - Analyst Alexandra Hauber JPMorgan - Analyst Graham Parry BAS-ML - Analyst Kevin Wilson Citigroup - Analyst... BriefCredit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/newstex/BW-0001-39198110BW-0001-39198110newstex/BW-0001-39198110xmlNewstex Inc.2005Parker Waichman Alonso LLPNewstex Inc.newstex.comnewstexBW-0001-39198110Business Wire0001Business WireBW1Newstex Inc.Business Wire0400000004012000040120040400500004005009020000000200200002002004020020060700000007014000070140190701401227 Oct 2009 05:27:49 EST180000001801400010/27/2009 Oct. ##, #### (Business Wire) -- Parker Waichman Alonso LLP announces that they have filed a lawsuit against GlaxoSmithKline and its subsidiaries on behalf of a South Carolina man who was diagnosed with neuropathy attributed to the...GLAXOSMITHKLINE PLCGSKNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-38905498BW-0001-38905498newstex/BW-0001-38905498xmlNewstex Inc.2005Parker Waichman Alonso LLPNewstex Inc.newstex.comnewstexBW-0001-38905498Business Wire0001Business WireBW1Newstex Inc.Business Wire0400000004012000040120040400500004005009020000000200200002002004020020060700000007014000070140190701401216 Oct 2009 03:19:14 EST180000001801400010/16/2009 Oct. ##, #### (Business Wire) -- Parker Waichman Alonso LLP announces that they have filed a lawsuit against GlaxoSmithKline and its subsidiaries on behalf of a Texas man who was diagnosed with neuropathy attributed to his use of Super...GLAXOSMITHKLINE PLCGSKNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-38798293BW-0001-38798293newstex/BW-0001-38798293xmlNewstex Inc.2005POZEN Inc.Newstex Inc.newstex.comnewstexBW-0001-38798293Business Wire0001Business WireBW1Newstex Inc.Business Wire04000000040020000400200604016000040160180401604807000000070140000701401214 Oct 2009 08:26:07 EST18000000180040001800800010/14/2009 Oct. ##, #### (Business Wire) -- POZEN Inc. (NASDAQ: POZN) , announced today that it will release third quarter #### results on October ##, ####, before the market opens. The announcement will be followed by a live webcast at ##:##...GLAXOSMITHKLINE PLCPOZEN INCGSKPOZNNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-38656988BW-0001-38656988newstex/BW-0001-38656988xmlNewstex Inc.2005Biotechnology Industry Organization (BIO)Newstex Inc.newstex.comnewstexBW-0001-38656988Business Wire0001Business WireBW1Newstex Inc.Business Wire040000000400200004002001130000001300200013002005130100001301000508 Oct 2009 06:19:31 EST180000001801800019000000190020001900200710/8/2009 Oct. #, #### (Business Wire) -- Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement today on the decision by David J. Kappos, Under Secretary of Commerce for Intellectual Property...GLAXOSMITHKLINE PLCGSKNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-38644096BW-0001-38644096newstex/BW-0001-38644096xmlNewstex Inc.2005Parker Waichman Alonso LLPNewstex Inc.newstex.comnewstexBW-0001-38644096Business Wire0001Business WireBW1Newstex Inc.Business Wire0400000004012000040120040400500004005009020000000200200002002004020020060700000007014000070140190701401208 Oct 2009 11:25:09 EST180000001801400010/8/2009 Oct. #, #### (Business Wire) -- Parker Waichman Alonso LLP announces that they have filed a lawsuit against GlaxoSmithKline and its subsidiaries on behalf of a North Carolina woman who was diagnosed with neuropathy attributed to the...GLAXOSMITHKLINE PLCGSKNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/MW-0001-38638168MW-0001-38638168newstex/MW-0001-38638168xmlNewstex Inc.2005Copyright (c) 2009, Marketwire. All rights reserved. All the news releases provided by Market Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited.RetroVirox Inc.SAN DIEGO, CANewstex Inc.newstex.comnewstexMW-0001-38638168Marketwire0001MarketwireMW1Newstex Inc.Marketwire09000000090150000400000004002000040020060401600004016008070000000701400007014012070030000700300113000000130100001301000508 Oct 2009 08:22:49 EST180000001800700019000000190010001900100510/8/2009 SAN DIEGO, CA, Oct. #, #### (Marketwire delivered by Newstex) -- SAN DIEGO, CA -- (Marketwire) -- ##/##/## -- RetroVirox, Inc., a biotechnology company focused on developing novel antivirals, announced today the appointment of Ronald...ASTRAZENECA PLCGLAXOSMITHKLINE PLCNOVARTIS AGAZNGSKNVSNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-38631186BW-0001-38631186newstex/BW-0001-38631186xmlNewstex Inc.2005APP Pharmaceuticals, Inc.Newstex Inc.newstex.comnewstexBW-0001-38631186Business Wire0001Business WireBW1Newstex Inc.Business Wire0700000007014000070140120700300007003001130000001301000013010005040000000400200004002006040160000401600108 Oct 2009 02:22:39 EST180000001802000018016000190000001900100010/8/2009 Oct. #, #### (Business Wire) -- APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ: APCVZ) announced today that it has received approval from the U.S. Food and Drug Administration...FRESENIUS KABI PHARMACEUTICALS HOLDING INC.GLAXOSMITHKLINE PLCAPCVZGSKNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-38613636BW-0001-38613636newstex/BW-0001-38613636xmlNewstex Inc.2005Parker Waichman Alonso LLPNewstex Inc.newstex.comnewstexBW-0001-38613636Business Wire0001Business WireBW1Newstex Inc.Business Wire04000000040120000401200404005000040050090200000002002000020020040200200607000000070140000701401907 Oct 2009 11:26:18 EST180000001801400019002004190010101900200710/7/2009 Oct. #, #### (Business Wire) -- Parker Waichman Alonso LLP announces that they have filed a lawsuit against GlaxoSmithKline and its subsidiaries on behalf of a Georgia woman who was diagnosed with neuropathy attributed to the use of...GLAXOSMITHKLINE PLCGSKNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-38609158BW-0001-38609158newstex/BW-0001-38609158xmlNewstex Inc.2005Cardiokine, Inc.Newstex Inc.newstex.comnewstexBW-0001-38609158Business Wire0001Business WireBW1Newstex Inc.Business Wire09000000090150000400000004002000040020060401600004016008070000000701400007014012070030000700300113000000130100001301000507 Oct 2009 10:24:12 EST18000000180070001900200410/7/2009 Oct. #, #### (Business Wire) -- Cardiokine, Inc., a privately-held specialty pharmaceutical company focused on the development of pharmaceuticals for the treatment and prevention of cardiovascular diseases, today announced that Amber...BIOGEN IDEC INCGLAXOSMITHKLINE PLCBIIBGSKNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-38494102BW-0001-38494102newstex/BW-0001-38494102xmlNewstex Inc.2005Parker Waichman Alonso LLPNewstex Inc.newstex.comnewstexBW-0001-38494102Business Wire0001Business WireBW1Newstex Inc.Business Wire04000000040120000401200404005000040050090200000002002000020020040200200607000000070140000701401902 Oct 2009 11:22:34 EST180000001801400019000000190010001900100910/2/2009 Oct. #, #### (Business Wire) -- Parker Waichman Alonso LLP announces that they have filed a lawsuit against GlaxoSmithKline and its subsidiaries on behalf of a woman who was diagnosed with severe neurological injuries attributed to...GLAXOSMITHKLINE PLCGSKNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-38148915BW-0001-38148915newstex/BW-0001-38148915xmlNewstex Inc.2005Zacks.comNewstex Inc.newstex.comnewstexBW-0001-38148915Business Wire0001Business WireBW1Newstex Inc.Business Wire0400000004016000040160050401604822 Sep 2009 08:54:30 EST18000000180160009/22/2009 Sep. ##, #### (Business Wire) -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks...GLAXOSMITHKLINE PLCHEWLETT PACKARD COPEROT SYSTEMS CORPROSS PEROTROSS PEROT JRGSKHPQPERNewsNewstexINDIA - GlaxoSmithKline PLC of the UK was rumored to be planning to acquire a #% stake, or #.### mil ordinary shares in Dr Reddy's Laboratories Ltd, a Hyderabad- based manufacturer, distributor and marketer of prescription pharmaceuticals. Terms were not disclosed but, according to sources close to the situation, the deal was valued at an estimated INR #. ### bil (USD ### mil).22 Sep 2009 08:00:08 EST37733W25613537733W256135GlaxoSmithKline PLCDr Reddy's Laboratories LtdGlaxoSmithKline PLCDr Reddy's Laboratories Ltdhttp://www.alacrastore.com/storecontent/Thomson_M%26A/GlaxoSmithKline_PLC_is_rumored_to_be_looking_for_a_minority_stake_in_Dr_Reddy_s_Laboratories_Ltd-2109540040sdc/21095400402109540040Copyright © 2009, Thomson Financial, All Rights ReservedLondonDrugsUnited KingdomPharmaceutical preparations2834FFForeignPublicGSK2023:Dry, condensed, and evaporated dairy products2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances2844:Perfumes, cosmetics, and other toilet preparations5122:Drugs, drug proprietaries, and druggists' sundries5149:Groceries and related products, nec8731:Commercial physical and biological research2023:Dry, condensed, and evaporated dairy products2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances2844:Perfumes, cosmetics, and other toilet preparations5122:Drugs, drug proprietaries, and druggists' sundries5149:Groceries and related products, nec8731:Commercial physical and biological researchNew YorkDrugsIndiaPharmaceutical preparations2834FFForeignPublicRDY9375003Mnfr pharmMnfr,whl pharmNot ApplicableOrdinary Share482722001Sep 22 20094.12100110.71100286.92800286.92800164.68000327.8180064.3930027.37800694.254000.516000.56700188.93600-1.07300-180.58800-131.444001358.65900117.031001435.07200STG30 Jun 090.000007532.738000.0000043316.1220054978.28200British Pound31 Mar 0931 Mar 0931 Mar 0831 Mar 0731 Mar 0631 Mar 050.020001.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.0000013.0000014.0000015.0000016.0000017.0000018.0000019.0000020.0000021.0000022.0000023.0000024.0000025.0000026.0000027.0000028.0000029.0000030.0000031.0000032.0000033.0000034.0000035.0000036.0000037.0000038.00000GlaxoSmithKline PLC, locatedin London, UK, manufactures,wholesales and developsprescription pharmaceuticalsand consumer health includingbiotech products, antibioticsand vaccines such as medicinesin the therapeutic areas ofrespiratory, central nervoussystem, anti-virals,anti-bacterials,anti-bacterials/anti-malarials, metabolic, vaccines,oncology and emesis, andcardiovascular and urogenital.The company's product brandsincludes Serevent, Wellbutrin,Lamictal, Requip, Combivir,Ziagen, Trizivir, Zeffix,Valtrex, Augmentin, Zinnat,Malarone, Lapdap, Avandia,Avandamet, Avandaryl, Twinrix,Fluarix, Infanrix, Zofran,Hycamtin, Bexxar, Coreg,Levitra, Avodart, Arixtra,Fraxiparine, Integrilin,Seretide/Advair,Flixotidel/Flovent,Flixonase/Flonase, Beconase,Seroxat/Paxil,Imigran/Imitrex, Panadol,Zovirax, Abreva, Tums,Citrucel, Contac, Beechams,Commit, Nicorette, NicodermCQ, NiQuitin CQ, Nicabate CQ,Abtei, Aquafresh, Dr. Best andOdol. The company was foundedin 1700.GlaxoSmithKline PLC, located in London, UK, manufactures,wholesales and develops prescription pharmaceuticals andconsumer health including biotech products, antibiotics andvaccines such as medicines in the therapeutic areas ofrespiratory, central nervous system, anti-virals,anti-bacterials, anti-bacterials/anti-malarial s, metabolic,vaccines, oncology and emesis, and cardiovascular andurogenital. The company's product brands includes Serevent,Wellbutrin, Lamictal, Requip, Combivir, Ziagen, Trizivir,Zeffix, Valtrex, Augmentin, Zinnat, Malarone, Lapdap,Avandia, Avandamet, Avandaryl, Twinrix, Fluarix, Infanrix,Zofran, Hycamtin, Bexxar, Coreg, Levitra, Avodart, Arixtra,Fraxiparine, Integrilin, Seretide/Advair,Flixotidel/Flovent, Flixonase/Flonase, Beconase,Seroxat/Paxil, Imigran/Imitrex, Panadol, Zovirax, Abreva,Tums, Citrucel, Contac, Beechams, Commit, Nicorette,Nicoderm CQ, NiQuitin CQ, Nicabate CQ, Abtei, Aquafresh, Dr.Best and Odol. The company was founded in 1700.GlaxoSmithKline PLC, located in London, UK, manufactures, wholesales and develops prescription pharmaceuticals and consumer health including biotech products, antibiotics and vaccines such as medicines in the therapeutic areas of respiratory, central nervous system, anti-virals, anti-bacterials, anti-bacterials/anti-malarial s, metabolic, vaccines, oncology and emesis, and cardiovascular and urogenital. The company's product brands includes Serevent, Wellbutrin, Lamictal, Requip, Combivir, Ziagen, Trizivir, Zeffix, Valtrex, Augmentin, Zinnat, Malarone, Lapdap, Avandia, Avandamet, Avandaryl, Twinrix, Fluarix, Infanrix, Zofran, Hycamtin, Bexxar, Coreg, Levitra, Avodart, Arixtra, Fraxiparine, Integrilin, Seretide/Advair, Flixotidel/Flovent, Flixonase/Flonase, Beconase, Seroxat/Paxil, Imigran/Imitrex, Panadol, Zovirax, Abreva, Tums, Citrucel, Contac, Beechams, Commit, Nicorette, Nicoderm CQ, NiQuitin CQ, Nicabate CQ, Abtei, Aquafresh, Dr. Best and Odol. The company was founded in 1700.1.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.0000013.0000014.0000015.0000016.0000017.0000018.0000019.0000020.0000021.00000Dr Reddys Laboratories Ltd,located in Hyderabad, India,manufactures, distributes andmarkets prescriptionpharmaceuticals intended forfinal consumption, includingbiotech products andantibiotics. The companyoperates in seven segmentsnamely Generics, ActivePharmaceutical Ingredients andIntermediates, Formulations,Critical Care andBiotechnology, CustomPharmaceutical Services, DrugDiscovery and Other. Thecompany has offices andoperations in North America,Russia and Europe and othercountries. The company wasfounded in 1984.Dr Reddys Laboratories Ltd, located in Hyderabad, India,manufactures, distributes and markets prescriptionpharmaceuticals intended for final consumption, includingbiotech products and antibiotics. The company operates inseven segments namely Generics, Active PharmaceuticalIngredients and Intermediates, Formulations, Critical Careand Biotechnology, Custom Pharmaceutical Services, DrugDiscovery and Other. The company has offices and operationsin North America, Russia and Europe and other countries. Thecompany was founded in 1984.Dr Reddys Laboratories Ltd, located in Hyderabad, India, manufactures, distributes and markets prescription pharmaceuticals intended for final consumption, including biotech products and antibiotics. The company operates in seven segments namely Generics, Active Pharmaceutical Ingredients and Intermediates, Formulations, Critical Care and Biotechnology, Custom Pharmaceutical Services, Drug Discovery and Other. The company has offices and operations in North America, Russia and Europe and other countries. The company was founded in 1984.0.000000.000000.00000168.67000YIndian Rupee18 Sep 09Fri, 18 Sep 2009 00:00:00 ESTDate Announced: 09/18/2009Date Effective:Acq. Part. Int.Not Appl.0.000000.000000.000000.000000.000000.00000Price/Share0.000000 Indian Rupee0.000000.000000 Indian Rupee0.000000.000000.000000.000000.0000014353.000000 Indian Rupee0.02100N0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000005.000000.000000.000000.000000.000000.000000.00000-15.733002.09100104305.3000017.3630016.7230016.57400-6.4440079.925000.254000.000000.000000.00000276.276002814.04100694.25400-6.0910016.084000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.0000013.0000014.00000INDIA - GlaxoSmithKline PLCof the UK was rumored to beplanning to acquire a 5%stake, or 8.433 mil ordinaryshares in Dr Reddy'sLaboratories Ltd, a Hyderabad-based manufacturer,distributor and marketer ofprescription pharmaceuticals.Terms were not disclosed but,according to sources close tothe situation, the deal wasvalued at an estimated INR 7.215 bil (USD 150 mil).INDIA - GlaxoSmithKline PLC of the UK was rumored to be planning to acquire a 5% stake, or 8.433 mil ordinary shares in Dr Reddy's Laboratories Ltd, a Hyderabad- based manufacturer, distributor and marketer of prescription pharmaceuticals. Terms were not disclosed but, according to sources close to the situation, the deal was valued at an estimated INR 7. 215 bil (USD 150 mil).INDIA - GlaxoSmithKline PLC of the UK was rumored to be planning to acquire a 5% stake, or8.433 mil ordinary shares in Dr Reddy's Laboratories Ltd, a Hyderabad- based manufacturer,distributor and marketer of prescription pharmaceuticals. Terms were not disclosed but,according to sources close to the situation, the deal was valued at an estimated INR 7.215 bil (USD 150 mil).INDIA - GlaxoSmithKline PLC of the UK was rumored to be planning to acquire a 5% stake, or 8.433 mil ordinary shares in Dr Reddy's Laboratories Ltd, a Hyderabad- based manufacturer, distributor andmarketer of prescription pharmaceuticals. Terms were not disclosed but, according to sources close to the situation, the deal was valued at an estimated INR 7. 215 bil (USD 150 mil).INDIA - GlaxoSmithKline PLC of the UK was rumored to be planning to acquire a 5% stake, or 8.433 mil ordinary shares in Dr Reddy'sLaboratories Ltd, a Hyderabad- based manufacturer, distributor and marketer of prescription pharmaceuticals. Terms were not disclosedbut, according to sources close to the situation, the deal was valued at an estimated INR 7. 215 bil (USD 150 mil).Rumor8031.000004575.0000026308.0000033391.00000209.3030014573.0000014573.000008364.0830016649.815003270.498001390.5330035261.000009596.00000-54.4800026.0700060.920009.585002.15000-54.4800035261.0000035261.0000044968.8430039983.0740020688.7960019417.75400-9172.000004381.325009658.878001467.29800329.11600-9172.00000-6676.000005288.4900012414.967001991.57900190.44000-6676.0000069006.0000049916.7700065255.9980023626.698000.0000069006.0000072887.0000072887.0000076966.3780077085.5440063270.2890028035.35200Status:RumorRE-999.00000np0.00000-999.00000np0.000000.000000.000002.833000.00000694.25400-2.7610026.980009.9020015.038004.092002833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances5122:Drugs, drug proprietaries, and druggists' sundries8731:Commercial physical and biological research8742:Management consulting services9375003LondonUnited Kingdom2834ForeignPublicGSK2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances5122:Drugs, drug proprietaries, and druggists' sundries8731:Commercial physical and biological research8742:Management consulting services482722001New YorkIndia2834ForeignPublicRDY0.000000.000000.000000.00000Deal InformationTF Mergers & Acquisitionshttp://www.alacrastore.com/storecontent/newstex/BW-0001-38140464BW-0001-38140464newstex/BW-0001-38140464xmlNewstex Inc.2005Zacks.comNewstex Inc.newstex.comnewstexBW-0001-38140464Business Wire0001Business WireBW1Newstex Inc.Business Wire04000000040090000401600004016048040160180401600121 Sep 2009 07:29:39 EST180000001800800018004000180060009/21/2009 Sep. ##, #### (Business Wire) -- Stock picks from the Value Method (VM#) strategy are being spotlighted today by Zacks, the nation’s largest independent stock research firm. This strategy surged +##.#% during ####, while the S&P ###...AEROCENTURY CORPAMERICAN STATES WATER COEPICOR SOFTWARE CORPGLAXOSMITHKLINE PLCACYAWREPICGSKNewsNewstex